Gale down 20% premarket

Off hours trading still going the wrong way for Galena Biopharma (GALE).

Investors appear to be holding their collective noses over Abstral results and legal distractions.

From other sites
Comments (8)
  • Zubunda
    , contributor
    Comments (202) | Send Message
    Isn't an investigation by the SEC considered material information which must be disclosed within a few days?! According to the 10-k, the investigation started in Feb! Notwithstanding, it is possible that the investigation started long before GALE got information about this, and thet they recieved the information conveniently just before the scheduled ernings release... Still, one has but to marvel at the stupidity of management! Don't think they can peddle Abstral in the amounts needed to offset this calamity!
    18 Mar 2014, 07:43 AM Reply Like
  • pat walsh
    , contributor
    Comments (341) | Send Message
    I think the board members who sold stock should give the money they made back to company.get on their knees and apologize then commit suicide.IT'S THE RIGHT THING TO DO.
    18 Mar 2014, 08:24 AM Reply Like
  • liotrade
    , contributor
    Comment (1) | Send Message
    Call Dr. Frost of OPK learn how to promote company stock price: buy it! Not sell it
    18 Mar 2014, 08:38 AM Reply Like
  • Poteat
    , contributor
    Comment (1) | Send Message
    I don't know what to do now. Time to sell?
    18 Mar 2014, 08:39 AM Reply Like
  • Idiota
    , contributor
    Comments (35) | Send Message
    Time to buy is coming with 2 year horizon on 150% upside. Still promising on Abstral. Can't beat the price now & it'll bottom out at approximately $2.40 in my humble estimation.
    18 Mar 2014, 08:41 AM Reply Like
  • inkyx
    , contributor
    Comments (523) | Send Message
    Poteat, Well, I wouldn't sell now. Much like riding a rodeo horse, there's a good and bad time to get off. Getting bucked off (reacting to bad news) is not good. I'd rather look at the markets reaction to this via price and volume. Today may be a day to purchase more, or sit on the sidelines.
    18 Mar 2014, 08:42 AM Reply Like
  • tracypawlak
    , contributor
    Comments (2) | Send Message
    I'm not sure shareholders are holding their collective noses at the Abstral results. I believe it's the SEC investigation that stinks.
    18 Mar 2014, 09:39 AM Reply Like
  • el financiero
    , contributor
    Comments (6) | Send Message
    I'm going long on GALE. Double down.
    18 Mar 2014, 09:42 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs